GlassScriptPhysician profile
Lyndon C Box
NPI 1174620512
$5,664.42
in general payments reported to CMS, 2019-2025
32 companies · $1,104 in 2025
The $1,104 reported for 2025 was less than what a typical Interventional Cardiology provider received nationally (typical 2025 total: $1,092).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $2,422 · 2020: $127 · 2021: $456 · 2022: $299 · 2023: $257 · 2024: $1,000 · 2025: $1,104.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $2,361.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $2,360.91 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Cardiovascular Systems INC. | $2,076.81 | 2019 | |
| Boston Scientific Corporation | $436.75 | 2021-2025 | General - Ep, Farapulse, Varithena Administration Pack |
| Novartis Pharmaceuticals Corporation | $402.42 | 2019-2025 | |
| Astrazeneca Pharmaceuticals LP | $396.25 | 2019-2025 | Farxiga, Wainua |
| Shockwave Medical, INC | $370.55 | 2024-2025 | Shockwave Intravascular Lithotripsy (Ivl) System With The Shockwave E8 Peripher, Shockwave Ivl System With The Shockwave C2 Coronary Ivl Catheter |
| Abbott Laboratories | $263.67 | 2019-2025 | Esprit |
| Medtronic, INC. | $220.60 | 2022-2025 | Symplicity G3, Corevalve Evolut R, Venaseal |
| Pfizer INC. | $161.25 | 2023-2025 | |
| Amgen INC. | $146.83 | 2019-2025 | Repatha |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $133.77 | 2024-2025 | Lifevest |
| Novo Nordisk INC | $132.77 | 2024-2025 | Wegovy |
| Edwards Lifesciences Corporation | $107.11 | 2023-2025 | Edwards Sapien 3 Transcatheter Heart Valve (Thv), Proplege Device Kit |
| Philips North America LLC | $106.24 | 2019-2023 | |
| Janssen Pharmaceuticals, INC | $79.12 | 2021-2022 | |
| Cook Medical LLC | $73.48 | 2019 |
Show all 32 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Chiesi USA, INC. | $70.29 | 2024 | Kengreal |
| Medtronic Vascular, INC. | $59.02 | 2020 | |
| Esperion Therapeutics, INC. | $57.34 | 2020-2021 | |
| Bard Peripheral Vascular, INC. | $49.96 | 2021 | |
| Alnylam Pharmaceuticals INC. | $47.61 | 2024-2025 | Amvuttra |
| Arbor Pharmaceuticals, INC. | $37.23 | 2019-2020 | |
| E.R. Squibb & Sons, L.L.C. | $29.95 | 2025 | Camzyos |
| Getinge USA Sales, LLC | $26.32 | 2019-2020 | |
| Kiniksa Pharmaceuticals International, Plc | $24.91 | 2024 | Arcalyst |
| Canon Medical Systems USA, INC. | $23.62 | 2024 | Interventional Angiography System |
| Asahi Intecc USA, INC. | $22.78 | 2024 | Peripheral Vascular |
| Irhythm Technologies, INC. | $20.21 | 2019 | |
| Recor Medical INC | $20.12 | 2024 | Paradise Renal Denervation System |
| Abiomed | $19.80 | 2025 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $19.51 | 2024 | Jardiance |
| Bayer Healthcare Pharmaceuticals INC. | $14.68 | 2025 | |
| Sanofi-Aventis U.S. LLC | $13.45 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Lyndon Box listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.